How ALC (Alcon) Makes Money in 2025: A Deep-Dive With Income Statement

Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io

Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.

Understanding how a healthcare technology provider like ALC Income Statement Overview makes money is essential for investors and anyone interested in the business of healthcare technology. In this post, we break down ALC's quarterly income statement (Q2 2025) using a Sankey chart to visualize the financial flows — what comes in, where it goes, and what's left as profit.

Quick ALC Overview

ALC Income Statement Overview operates as a leading provider of healthcare technology solutions, focusing on advanced medical devices and digital health platforms. Revenue comes primarily from the sale of medical devices, software subscriptions, and related healthcare services. The company’s business segments include device sales, digital health solutions, and service contracts, each contributing to overall growth and diversification.

Revenue Breakdown

• Total Revenue (Q2 2025): $2.60B (+3.4% YoY)
  • Device Sales: $1.80B (69% of total)
  • Digital Health Solutions: $0.55B (21% of total)
  • Service Contracts: $0.25B (10% of total)
  • Growth is powered by increased adoption of digital health platforms and expansion into new healthcare markets.

Gross Profit and Margins

• Gross Profit: $1.39B (53.5% gross margin)
  • Cost of Revenue: $1.21B (+7.0% YoY)
  • ALC maintains robust margins due to its scalable digital business model and operational efficiencies in manufacturing and service delivery.
• Most costs come from:
  • Manufacturing and supply chain for devices
  • Technology infrastructure for digital health platforms
  • Service delivery and support

Operating Income and Expenses

• Operating Income: $247M (-22.3% YoY, 9.5% margin)
• Operating Expenses: $1.14B (+8.0% YoY)
  • R&D: $245M (+11.4% YoY, 9.4% of revenue) — Focused on next-generation medical devices and AI-driven healthcare analytics
  • SG&A: $870M (+3.9% YoY, 33.5% of revenue) — Includes sales teams, marketing, and administrative support for global operations
  • ALC continues to prioritize innovation and invest in growth while maintaining efficiency in its core operations.

Net Income

• Pre-Tax Income: $199M (-28.9% YoY, 7.7% margin)
• Income Tax: $23M (11.6% effective tax rate)
• Net Income: $176M (-21.1% YoY, 6.8% net margin)
• ALC converts a moderate portion of sales into profit due to its scalable technology offerings and disciplined cost management.

Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.

Want to see what we'll uncover next - before everyone else does?

Find Hidden Gems First!

What Drives ALC's Money Machine?

• Device Sales: 69%+ of revenue, driven by strong demand for advanced medical devices in hospitals and clinics
• Digital Health Platform Usage: Over 21% of revenue, with rapid growth in recurring software subscriptions and data analytics services
• Strategic R&D Investment: $245M in Q2 2025, targeting AI, remote monitoring, and next-gen device development
• Future Growth Areas: Expansion into telehealth and international markets, though these segments are not yet profitable

Visualizing ALC's Financial Flows

The Sankey chart below visualizes how each dollar flows from gross revenue, through costs and expenses, down to net income. This helps investors spot where value is created, what areas weigh on profits, and how efficiently the company operates.

• Most revenue flows into gross profit, with operating expenses (especially SG&A) taking the largest chunk.
• Even after significant investments in R&D and SG&A, 6.8% of revenue drops to the bottom line.

Key Takeaways

• ALC's money comes overwhelmingly from device sales, supported by growing digital health revenues
• High gross and net margins illustrate the power of ALC's scalable technology business model
• Heavy investment in R&D, balanced by efficiency in operating costs
• Ongoing growth is driven by digital health adoption and international expansion

Explore More Investment Opportunities

For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:

📌 50 Undervalued Stocks (Best) overall value plays for 2025
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)

🔍 Check out these stocks on the Value Sense platform for free!

FAQ About ALC's Income Statement

1. What is the main source of ALC's revenue in 2025?

ALC generates over 69% of its revenue from device sales. Additional revenue comes from digital health solutions and service contracts, which together account for about 31% of total revenue.

2. How profitable is ALC in Q2 2025?

ALC reported net income of $176M in Q2 2025, with a net margin of approximately 6.8%, reflecting moderate profitability driven by scalable technology offerings and disciplined cost management.

3. What are the largest expense categories for ALC?

The biggest expenses on ALC's income statement are operating expenses, particularly Research & Development (R&D) and Sales, General & Administrative (SG&A) costs. R&D investment reached $245M in Q2 2025, as ALC prioritizes next-generation device development and digital health innovation.

4. Why does the digital health segment operate at a loss?

Digital health, despite generating $550M in revenue, posted an operating loss of over $50M in Q2 2025. This is because ALC aggressively invests in platform development and international expansion, believing these will drive long-term growth—even if the division is unprofitable today.

5. How does ALC's effective tax rate compare to previous years?

ALC's effective tax rate in Q2 2025 was 11.6%, consistent with previous years. This moderate rate is primarily due to tax benefits from share-based compensation and international structuring.